Baseline biochemical and clinical predictors of castration resistance and survival in metastatic hormone-sensitive prostate cancer treated with first-line androgen receptor pathway inhibitors: A multicenter real-world study.

F. Verdasca, João Gramaça, I. Guerreiro et al.|Journal of Clinical Oncology|2026

Cited by 0